ENOV
ENOV
NYSE · Health Care

Enovis Corp

$26.61
+0.30 (+1.14%)
As of Aug 8, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.98B
Net Income
-1,041,003,135
Gross Margin
58.2%
Profit Margin
-52.7%
Rev Growth
+12.9%
D/E Ratio
0.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.98B 1.75B 959.49M 1.06B
Gross Profit 1.15B 1.02B 638.34M 705.58M
Operating Income -989,679,649 -789,078,387 89.71M 107.61M
Net Income -1,041,003,135 -829,998,955 74.78M 72.61M
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Rev Growth +12.9% +12.9% -5.1% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 340.22M 340.22M 570.05M 575.91M
Total Equity 390.83M 390.83M 642.51M 611.09M
D/E Ratio 0.87 0.87 0.89 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -674,878,720 -567,979,078 123.09M 130.61M
Free Cash Flow 63.08M 92.88M